Ramsay Health Care (ASX:RHC) Nears an 80% Yearly Gain, Santé Reshapes Its Next Chapter

Sonal Goyal

08 November 2026 11:42 PM AEDT

Ramsay Health Care (ASX:RHC) Nears an 80% Yearly Gain, Santé Reshapes Its Next Chapter

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Shares closed at AUD55.75 on 6 November 2026, with an annual gain of nearly 80%.
Ramsay Santé reported quarterly Revenue of EUR1,232.9 million and EBITDA of EUR120.7 million.
The proposed distribution of Ramsay’s Santé holding remains subject to approvals and completion.

Ramsay Health Care (ASX:RHC) operates private healthcare services across Australia, the United Kingdom and Europe. Its shares closed at AUD55.75 on 6 November 2026, down 0.46% for the session, while retaining a gain of nearly 80% over a year. The annual advance provides the backdrop to an ownership restructuring proposal and an improved quarterly Earnings result at its European subsidiary, Ramsay Santé.

An annual advance alongside European earnings growth

Ramsay Health Care released Ramsay Santé’s results for the three months ended 30 September 2026 on 6 November. Ramsay held 52.79% of the subsidiary. The European Business reported revenue of EUR1,232.9 million, increasing 2.9% year on year, or 2.6% at constant exchange rates. These are Subsidiary figures and should not be presented as Ramsay’s consolidated group revenue.

Santé’s EBITDA increased 7.5% to EUR120.7 million, with its Margin rising to 9.8% from 9.4%. Activity growth in France and price indexation in the Nordic region supported trading. The result also reflected the contribution of the new St Göran contract. The operating improvement gives a more specific measure of progress than the annual share price gain alone.

Cash flow improves while Debt remains substantial

For Ramsay Health Care, Santé’s financial position remains relevant to the proposed ownership change. The subsidiary’s net loss attributable to its group shareholders narrowed to EUR35.5 million from EUR40.1 million. Higher EBITDA therefore did not translate into a quarterly Bottom Line profit.

Santé recorded operating cash outflow of EUR3.3 million, compared with EUR43.5 million a year earlier. Net financial debt was EUR3,730 million, including Lease liabilities. Its restated debt measure before IFRS 16 was EUR1,788 million, and the corresponding Leverage Ratio was 5.1 times, compared with 5.2 times a year earlier.

In July 2026, Santé refinanced EUR1.75 billion through a EUR1.55 billion term Loan and a EUR200 million revolving facility, extending maturities from 2031 to 2033. Santé operates within a separate, self funded financing structure that is nonrecourse to Ramsay’s Australian and parent funding group.

A proposed distribution defines the next milestone

Ramsay Health Care plans to distribute its 52.79% Santé holding to Ramsay shareholders. The proposal includes an application for an ASX foreign exempt listing through depositary interests. Approvals and completion conditions remain outstanding; the transaction should not be described as completed.

Alongside the proposal, Santé is implementing its Connecting Care 2030 programme, with Investment in radiotherapy and PET services and attention to costs and its Facility network. Execution, patient activity and financing requirements remain relevant measures as the businesses prepare for potential ownership changes.

Key Insights

Ramsay Health Care combines a strong annual price advance with a planned change to its European investment. Santé’s EBITDA and Cash Flow improved, although its quarterly loss and debt remain material. The next assessment depends on operating delivery and the conditions attached to the proposed distribution.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.